Member Info for Howzaty

Bolly on ..

Folk seem to forget AS commenting in the last presesentation something along the lines of "we have to be careful, we dont want the share price running away because we want companies to invest". Avacta directors are not thick they knew exactly the consequences of the loan and this has kept the brakes on the SP thus far. But when Precision is proven beyond any doubt, brakes arnt going to hold the SP and the long awaited inflection point will be reached. But we may be bought out sooner if just one BP wants to get the drop on others. Only my opinion but long to wait now. I cant believe AS will stand there on Weds telling us he got it wrong so get the Olly on ice.

For BF there is the inherent risk of missing out on what is possibly one of the biggest opportunities of recent and perhaps not so recent years. Given the wide scope of Precision (i.e. ADC applicability) my feeling is that an offer could come out the blue at any point, including prior to Wednesday's presentation. Fingers crossed.

"You can either read market sentiment and its likely direction, or YOU can't!" and in my opinion you havent got a Scooby. But we shall see soon enough.

AS paraphrased and briefly answered one of my written questions, which some may have missed "Why given the success the company has achieved in its P1a trial and the huge potential benefit to cancer patients all over the world is their no coverage in Global media." To paraphrase his answer "now that we have patients being treated with Chemo not experiencing adverse symptoms we are approaching the point where we can engage with Global Media. " Very good to hear say I.

I tend to agree with others that the Author is being obtuse at best and possibly has an agenda which he is attempting to complete. Not for me.

Yes the "18 to 24 months" didnt do much for me either.

I think youll find the loan provider decides whether repayment is cash or shares. If you have info to the contrary please post. Ta.

Just how exactly do we find ourselves at 123p again. Please dont tell me more sells than buys!

About that "poor report" curiously with the Avacta Pre|CISION Platform given the likelyhood of a high MTD treatments may well be tailored to Tumour specifics of the indiviual at least so Precision Pre|CISION.

Well, Strong Buy bearly covers it. The video points to earth shattering improvement in Cancer Care. Surely Avacta will achieve its licensing goal or be bought out in short order. We have a Gold Standard of care here.

"Think Avacta are presenting on Sunday." Yep, Sunday 16th at 1:30.

I should have said in todays RNS.

Its good to see the words "... has the potential to ..." finally dropped from the about Avacta text. Small observation perhaps but I have been waiting and watching for this for some time. Lets hope its lost from all other presentation material as well.

For information there is an EU directive or similar which states that it is an objective/ goal for the use of Antibodies developed in animals to be discontinued in coming years. Another reason why I chose to invest in Avacta several years ago. Dont have the time to dig it out but be assured it exists.

"Massive profit" you forget that adjustment for share appreciation was written in to the contract.

Well, lets imagine Avacta owed 50M, which was required to be paid back in shares, would the BOD now be thinking about how to move the SP from its current value of around 135p to nearer 1000p? The answer is clear to me folks!

Well I learned quite a bit from SD. That Cancer as a disease even the the same type can vary quite consiserably in its composition between individuals and consequently the results of tests can be more nuanced than I expected. That trials themselves can be more complex and nuanced that I expected as well so that my previous black and white understanding has now taken on a myriad shades of grey. But above all this is confirmation from an expert of something I stated months if not years ago that if AVA6000 is as it appears to be a better form of Dox it will capture the entire Global market and moreover will increase market size perhaps very, very significantly. Finally I learned that it works and may well be fast tracked to market even though the road will be a little longer than I expected with my previosly simplistic view of things. It works, it will save and improve many lives and make Avacta a heap of money one way or another. So for me its time to chill and look at this board a little less often. Well done the Faithfull , you were right all along, it works and it will be huge.

If Phase 1a data is to be presented as previously stated there will have to be an RNS on Thursday morning. It may be that the RNS will be technical to the extent that it will need explanation, dont see how data can be released without an RNS, I am looking forward to it actually.

"... MHRA.." or anything resembling MHRA approval where vested interest cancels all else. The good news is that vested interest should be fighting over Precision if not there is always the Chinese I guess.